Nuclear assembly as a target for anti-cancer therapies
Open Access
- 27 January 2014
- journal article
- review article
- Published by Taylor & Francis in Nucleus
- Vol. 5 (1) , 47-55
Abstract
Current anti-cancer therapies have a great deal of undesirable side effects; therefore, there is a need to develop efficient and cancer cell-specific new drugs without strong dose-limiting side eff...Keywords
This publication has 123 references indexed in Scilit:
- Mitosis-targeted anti-cancer therapies: where they standCell Death & Disease, 2012
- Repo-Man Coordinates Chromosomal Reorganization with Nuclear Envelope Reassembly during Mitotic ExitDevelopmental Cell, 2011
- Exome Sequencing and Functional Analysis Identifies BANF1 Mutation as the Cause of a Hereditary Progeroid SyndromeThe American Journal of Human Genetics, 2011
- Cell Cycle-Dependent Differences in Nuclear Pore Complex Assembly in MetazoaCell, 2010
- Molecular Maps of the Reorganization of Genome-Nuclear Lamina Interactions during DifferentiationMolecular Cell, 2010
- An integrated workflow for charting the human interaction proteome: insights into the PP2A systemMolecular Systems Biology, 2009
- The human granulocyte nucleus: Unusual nuclear envelope and heterochromatin compositionEuropean Journal of Cell Biology, 2008
- Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphomaCancer Chemotherapy and Pharmacology, 2007
- A Microtubule-Independent Role for Centrosomes and Aurora A in Nuclear Envelope BreakdownDevelopmental Cell, 2007
- Cyclin A2 Regulates Nuclear-Envelope Breakdown and the Nuclear Accumulation of Cyclin B1Current Biology, 2007